{"id":"W4367302757","doi":"10.1212/wnl.0000000000203101","title":"Integrated safety summary from Phase 3 clinical trials of IPX203, an extended-release carbidopa-levodopa formulation, in Parkinson disease (P1-11.006)","year":2023,"lang":"en","type":"article","venue":"Neurology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Adverse effect; Medicine; Carbidopa; Dosing; Levodopa; Dyskinesia; Population; Clinical trial; Internal medicine; Parkinson's disease; Anesthesia; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006998571,0.0008454005,0.001179679,0.001270119,0.0004557758,0.001560715,0.00147371,0.001417589,0.02106206],"category_scores_gemma":[0.007544016,0.0003753182,0.001810947,0.001371746,0.0001603228,0.0005591071,0.0005287346,0.001446234,0.005898021],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001182745,"about_ca_system_score_gemma":0.003111552,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001677601,"about_ca_topic_score_gemma":0.004700212,"domain_scores_codex":[0.9974655,0.0009429579,0.0003558502,0.0001654656,0.0008684687,0.0002017277],"domain_scores_gemma":[0.9917232,0.001526732,0.002500555,0.0004315071,0.002993716,0.0008242639],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.05403711,0.002330145,0.005281641,0.01518187,0.003342777,0.0004154645,0.000145253,0.002434375,0.0184397,0.001414434,0.27813,0.6188474],"study_design_scores_gemma":[0.0285742,0.04928586,0.05483936,0.004036888,0.008410939,0.001159601,0.00009115341,0.001642138,0.01612381,0.001760011,0.833965,0.0001110806],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"dataset","genre_gemma":"empirical","genre_scores_codex":[0.09842756,0.2257164,0.04214216,0.02365754,0.00600489,0.03190608,0.4062578,0.004082683,0.1618049],"genre_scores_gemma":[0.3034111,0.1112104,0.03266861,0.02871824,0.008723671,0.01811445,0.4262954,0.0005669245,0.07029125],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02106206,"threshold_uncertainty_score":0.07045954,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1992490419575181,"score_gpt":0.4832176173055595,"score_spread":0.2839685753480414,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}